Cargando…

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

Detalles Bibliográficos
Autores principales:	Rob, Daniel, Marek, Josef, Dostálová, Gabriela, Goláň, Lubor, Linhart, Aleš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249134/ https://www.ncbi.nlm.nih.gov/pubmed/28107535 http://dx.doi.org/10.1371/journal.pone.0170881

Ejemplares similares

Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease
por: Rob, Daniel, et al.
Publicado: (2016)

Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations
por: Rob, Daniel, et al.
Publicado: (2022)

Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease
por: Jirásková, Alena, et al.
Publicado: (2017)

Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis
por: Marek, Josef, et al.
Publicado: (2023)

Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey
por: Marek, Josef, et al.
Publicado: (2019)

Correction:Serum Uric Acid and Mortality Form Cardiovascular Disease:EPOCH-JAPAN Study
por: Zhang, Wen, et al.
Publicado: (2016)

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
por: Goláň, Lubor, et al.
Publicado: (2015)

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic
por: Zemánek, David, et al.
Publicado: (2022)

Correction to: Migalastat: A Review in Fabry Disease
por: McCafferty, Emma H., et al.
Publicado: (2019)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

Correction: The Correlation Between NAFLD and Serum Uric Acid to Serum Creatinine Ratio
por: Choi, Jangwon, et al.
Publicado: (2023)

Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis
por: Vítek, Libor, et al.
Publicado: (2022)

The Urinary Uric Acid / Cr ratio as a marker of morbidity and mortality of preterm infants: a case—control study
por: Sadeghzadeh, Mansour, et al.
Publicado: (2021)

Nationwide screening for Fabry disease in unselected stroke patients
por: Tomek, Aleš, et al.
Publicado: (2021)

Correction: Mortality and morbidity in wild Taiwanese pangolin (Manis pentadactyla pentadactyla)
Publicado: (2019)

Correction to: Ultrasonic signal detection based on Fabry–Perot cavity sensor
por: Yang, Wu, et al.
Publicado: (2021)

Correction: Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype
Publicado: (2017)

Correction: Fabry disease due to D313Y and novel GLA mutations
Publicado: (2018)

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study
por: Linhart, Aleš, et al.
Publicado: (2023)

Correction to: Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia
por: Wang, Yu, et al.
Publicado: (2021)

Correction to: A birth population-based survey of preterm morbidity and mortality by gestational age
por: Guo, Xiaojing, et al.
Publicado: (2021)

Correction: Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach
por: Sampaio, Vanderson de Souza, et al.
Publicado: (2020)

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
por: Dostálová, Gabriela, et al.
Publicado: (2017)

Correction to: The geriatric nutritional risk index mediated the relationship between serum uric acid and hypertension: a mediation analysis
por: Cao, Zhongnan, et al.
Publicado: (2021)

Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients
por: Keslová-Veselíková, Jana, et al.
Publicado: (2008)

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction
por: Hajizadeh, Reza, et al.
Publicado: (2016)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

Correction: Determinants of morbidity and mortality following emergency abdominal surgery in children in low-income and middleincome countries
Publicado: (2017)

Correction to: Correlation between polio immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study
por: Afify, Marwa Adel, et al.
Publicado: (2021)

Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
por: Bichet, Daniel G., et al.
Publicado: (2020)

Correction: The assessment of biases in the acoustic discrimination of individuals
por: Linhart, Pavel, et al.
Publicado: (2018)

Author Correction: Data based model for predicting COVID-19 morbidity and mortality in metropolis
por: Barcellos, Demian da Silveira, et al.
Publicado: (2022)

Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis
por: Hughes, Derralynn, et al.
Publicado: (2021)

Correction: Absence of Antiretroviral Therapy and Other Risk Factors for Morbidity and Mortality in Malaysian Compulsory Drug Detention and Rehabilitation Centers
por: Fu, Jeannia J., et al.
Publicado: (2013)

Correction to: Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study
por: Abayomi, Akin, et al.
Publicado: (2021)

Correction: Moderate elevation of serum uric acid levels improves short-term functional outcomes of ischemic stroke in patients with type 2 diabetes mellitus
por: Dai, Yalun, et al.
Publicado: (2023)

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
por: Ortiz, Alberto, et al.
Publicado: (2016)

Uric Acid—An Emergent Risk Marker for Thrombosis?
por: Țăpoi, Laura, et al.
Publicado: (2021)

Correction: Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience
por: Effraimidis, Grigoris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7egcbc20gara03me8aljk18jdh